# Alex Zhavoronkov

> Alex Zhavoronkov is the founder, chairman, co-CEO and chief business officer of Insilico Medicine. Born in Riga and educated at Queen’s University, Johns Hopkins University and Moscow State University, he previously worked at ATI Technologies. His public work spans AI research, company building and writing, including the 2012 book Dating AI. Insilico listed in Hong Kong in December 2025.

- **Role:** Founder, Chairman, Co-CEO and Chief Business Officer at Insilico Medicine
- **Organizations:** Insilico Medicine, ATI Technologies (former employer), Queen’s University (alumnus), Johns Hopkins University (alumnus), Moscow State University (alumnus)
- **From:** Riga, Latvia
- **Education:** Bachelor’s degrees in commerce and science, Queen’s University, Master’s degree in biotechnology, Johns Hopkins University, PhD in physics and mathematics, Moscow State University
- **Known for:** Founded Insilico Medicine in 2014 and led it through its December 2025 Hong Kong listing., Insilico’s initial public offering raised HK$2.277 billion., Authored Dating AI, published by RE/Search in 2012.

## Career timeline

- **2001** — Receives bachelor’s degrees in commerce and science from Queen’s University.
- **2006** — Discusses his departure from ATI Technologies in a September farewell interview.
- **2007** — Receives master’s degree from Johns Hopkins University.
- **2008** — Receives doctorate from Moscow State University.
- **2012** — Publishes Dating AI through RE/Search as Alex Zhavoronkoff.
- **2014** — Founds Insilico Medicine in Baltimore.
- **2025** — Publicly describes adding chief business officer responsibilities alongside his co-CEO role.
- **2025** — Coauthors The Right to Be Remembered preprint with Dominika Wilczok and Roman Yampolskiy.
- **2025** — Insilico lists on HKEX on December 30 under stock code 3696.
- **2026** — Insilico launches Science MMAI Gym in January and announces a Liquid AI partnership in March.

## Achievements

- Founded Insilico Medicine in 2014 and led it through its December 2025 Hong Kong listing.
- Insilico’s initial public offering raised HK$2.277 billion.
- Authored Dating AI, published by RE/Search in 2012.
- Named a Highly Cited Researcher by Clarivate for 2022, as recorded in his World Economic Forum biography.
- Coauthor of the 2026 MMAI Gym for Science paper.

## Latest updates

- **2026-10** — Appeared in a Fox Business interview with Liz Claman, distributed on October 16.
- **2026-08** — Insilico reported first-half 2026 revenue of US$106.3 million and net profit of US$35.54 million on August 26.
- **2026-07** — Foresight Institute published a recording of his company-building talk.
- **2026-03** — Insilico and Liquid AI announced a partnership producing a 2.6-billion-parameter scientific model for private infrastructure.
- **2026-01** — Insilico launched Science MMAI Gym on January 22.

## Links

- Website: https://alexzhavoronkov.com/
- LinkedIn: https://www.linkedin.com/in/zhavoronkov/
- Twitter/X: https://x.com/biogerontology

---

Profile page: https://yespress.io/alex-zhavoronkov
Published by YesPress — https://yespress.io
Last updated: 2026-10-25